Here's Why Wall Street is Bullish on TransMedics Group (TMDX) [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Hedge Funds . On August 4, TransMedics Group, Inc. (NASDAQ:TMDX) received conditional approval from the US FDA for its Investigational Device Exemption, allowing the company to start its Next-Generation OCS ENHANCE Heart trial. The trial has two parts, where the first part focuses on supporting prolonged heart perfusion using the OCS Heart System. Whereas the second part aims to prove that OCS Heart perfusion is better than traditional cold storage methods in hearts donated after brain death. Analysts have been bullish on the stock since the approval. On September 5, Josh Jennings from TD Cowen reiterated a Buy rating on TransMedics Group, Inc. (NASDAQ:TMDX) with a price target of $170. Earlier on September 3, Matthew O'Brien from Piper Sandler had also reiterated a Buy rating on the stock with a price target of $145. TransMedics Group, Inc. (NASDAQ:TMDX) is a medical technology company that revolutionizes organ transplant therapy for patients with end-stage lung, heart, and liv
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Morgan Stanley from $123.00 to $135.00. They now have an "equal weight" rating on the stock.MarketBeat
- TransMedics to Participate in the Piper Sandler 37th Annual Healthcare ConferencePR Newswire
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.MarketBeat
- TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..MarketBeat
TMDX
Earnings
- 10/29/25 - Beat
TMDX
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/3/25 - Form 144
- TMDX's page on the SEC website